title: Good efficacy and tolerability of ustekinumab in a patient with severe psoriasis under haemodialysis.
authors.affiliation: Department of Dermatologie, CHU Nancy, 29 Avenue du Maréchal de Lattre de Tassigny, 54000 Nancy, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Larquey
authors.affiliation: Department of Dermatologie, CHU Nancy, 29 Avenue du Maréchal de Lattre de Tassigny, 54000 Nancy, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Poreaux
authors.affiliation: Department of Dermatologie, CHU Nancy, 29 Avenue du Maréchal de Lattre de Tassigny, 54000 Nancy, France.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Cuny
authors.affiliation: Department of Dermatologie, CHU Nancy, 29 Avenue du Maréchal de Lattre de Tassigny, 54000 Nancy, France.
authors.forename: Annick
authors.initials: A
authors.lastname: Barbaud
authors.affiliation: Department of Dermatologie, CHU Nancy, 29 Avenue du Maréchal de Lattre de Tassigny, 54000 Nancy, France.
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Schmutz
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000628:therapy; D012720:Severity of Illness Index; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D000069549:Ustekinumab